MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Albendazole

Albendazole 200mg chewable tablets

No stability information

Stability notes for Albendazole 200mg chewable tablets

There are no stability notes for this medicine.

Supplier

Zentel 200mg chewable tablets (Imported (Australia))

Albendazole 400mg chewable tablets

No stability information

Stability notes for Albendazole 400mg chewable tablets

There are no stability notes for this medicine.

Suppliers

Albendazole 400mg chewable tablets (Special Order)
Zentel 400mg chewable tablets (Imported (United States))

Albendazole 400mg tablets

No stability information

Stability notes for Albendazole 400mg tablets

There are no stability notes for this medicine.

Suppliers

Albendazole 400mg tablets (Part VIIID Drug Tariff Special Order)
Eskazole 400mg tablets (Imported (France))

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.